Although millions of women, and more recently men, at risk for cancer have been tested for germline genetic variants in BRCA1 and BRCA2, diagnostic sequencing has continued to identify variants with uncertain relevance to cancer risk. The gene discussed is BRCA2; the disease is cancer.